Clinical Effects of Selective Serotonin Reuptake Inhibitors

Part of the Psychopharmacology Series book series (PSYCHOPHARM, volume 7)


Meta-analysis of controlled clinical trials has recently been established as a discipline that critically reviews and statistically combines the results of new treatment modalities. The objectives of a meta-analysis are to increase statistical power in detecting differences between treatments and to resolve un-certainties in the case of conflicting results. A meta-analytic literature review takes the trial itself as unit of analysis and consequently gives equal weight to each trial. A study of on-file data calculates the central tendency of the pooled data set, in which the individual patient in the trial is the unit for calculation of means, standard deviations, etc.


Selective Serotonin Reuptake Inhibitor Antidepressant Drug Hamilton Depression Scale Tricyclic Antidepres Global Improvement Scale 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amin M.M, Ananth J V, Coleman B S, Darcourt G, Farkes T, Goldstein B, Lapierre Y D, et al. (1984) Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study. Clin Neuropharmacol [Suppl 1] 7: 580–581Google Scholar
  2. Bech P (1988a) A review of the antidepressant properties of serotonin reuptake inhibitors. In: Gastpar M, Wakelin JS (eds) Selective 5-HT reuptake inhibitors: novel or commonplace agents? Karger, Basel, pp 58–69Google Scholar
  3. Bech P (1988b) Rating scales for mood disorders: applicability, consistency and construct validity. Acta Psychiatr Scand [Suppl 345] 78: 45–55CrossRefGoogle Scholar
  4. Bech P, Gram LF, Dein E, Jacobsen O, Vitger J, Bolwig TG (1975) Quantitative rating of depressive states. Acta Psychiatr Scand 51: 161–170PubMedCrossRefGoogle Scholar
  5. Bech P, Vendsborg PB, Rafaelsen OJ (1976) Lithium maintenance treatment of manic-melancholic patients: its role in the daily routine. Acta Psychiatr Scand 53: 70–81PubMedCrossRefGoogle Scholar
  6. Bech P, Shapiro R W, Sihm F, Nielsen B M, Sørensen B, Rafaelsen O J (1980) Personality in unipolar and bipolar manic-melancholic patients. Acta Psychiatr Scand 62: 245–257PubMedCrossRefGoogle Scholar
  7. Bech P, Allerup P, Reisby N, Gram LF (1984) Assessment of symptom change from improvement curves on the Hamilton Depression Scale in trials with antidepressants. Psychopharmacology (Berlin) 84: 276–281CrossRefGoogle Scholar
  8. Benfleld P, Ward A (1986) Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs 32: 313–334CrossRefGoogle Scholar
  9. Chovinard G (1985) A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. J Clin Psychiatry 46: 32–37Google Scholar
  10. Coppen A, Ghose K, Baily J, Christensen J, Mikkelsen PL, van Praag HM, van de Poel F et al. (1978) Amitriptyline plasma-concentration and clinical effect. Lancet 1: 63–66PubMedCrossRefGoogle Scholar
  11. Dick P, Ferrero E (1983) A double-blind comparative study of the clinical efficacy of fluvoxamine and clomipramine. Br J Clin Pharmacol 15: 419–425Google Scholar
  12. Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM (1985) A double-blind placebo- controlled study of fluvoxamine and imipramine in depression. J Clin Psychiatry 46: 84–87PubMedGoogle Scholar
  13. DU AG, Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology (Berlin) 90: 131–138Google Scholar
  14. EC, European Community (1987) Clinical investigation of antidepressant drugs. EC Brussels No 111/476/87Google Scholar
  15. Guelfi JD, Dreyfus JF, Pichot P, GEPECEP (1987) Fluvoxamine and imipramine: results of a long-term controlled trial. Int Clin Psyehopharmacol 2: 103–109Google Scholar
  16. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278–296PubMedCrossRefGoogle Scholar
  17. Itil TM, Shrivastava RK, Mukherjee S, Coleman BS, Michael ST (1983) A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression. Br J Clin Pharmacol 15: 433–438Google Scholar
  18. Kay DWK, Fahy T, Garside RF (1970) A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 117: 667–671PubMedCrossRefGoogle Scholar
  19. Klok CJ, Brouwer GJ, van Praag HM, Doogan D (1981) Fluvoxamine and clomipramine in depressed patients. Acta Psychiatr Scand 65: 1–11CrossRefGoogle Scholar
  20. Lapierre YD, Browne M, Horn E, Oyewumi LK, Sarantidis D, Roberts N, Badoe K, Tessier P (1987) Treatment of major affective disorder with fluvoxamine. J Clin Psychiatry 48: 65–68PubMedGoogle Scholar
  21. Medical Research Council (1965) Clinical trial of the treatment of depressive illness. Br Med J 1: 881–886Google Scholar
  22. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to 92 change. Br J Psychiatry 134: 382–389PubMedCrossRefGoogle Scholar
  23. Morris JB, Beck AT (1974) The efficacy of antidepressant drugs. Arch Gen Psychiatry 30: 667–674PubMedGoogle Scholar
  24. Norton KRW, Sireling LI, Bhat AV, Rao B, Paykel ES (1984) A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients. J Affect Dis 7: 297–308PubMedCrossRefGoogle Scholar
  25. Quitkin FM, Rabkin JG, Ross D, McGrath PJ (1984) Duration of antidepressant drug treatment. Arch Gen Psychiatry 41: 238–245PubMedGoogle Scholar
  26. Schou M (1976) Prophylactic and maintenance therapy in recurrent affective disorders. In: Gallant DM, Simpson GM (eds) Depression: behavioral biochemical, diagnostic and treatment concept. Spectrum, New York, pp 309–326Google Scholar
  27. Shaw DM (1986) A comparison of the antidepressant action of citalopram and amitriptylin. Br J Psychiatry 149: 515–517PubMedCrossRefGoogle Scholar
  28. Smith A, Traganza E, Harrison G (1969) Studies of the effectiveness of antidepressant drugs. Psyehopharmacol Bull [Special issue]: 1–21Google Scholar
  29. Stark P, Hardison DC (1985) A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 46: 53–58PubMedGoogle Scholar
  30. Wechsler H, Grosser GH, Greenblatt M (1965) Research evaluating antidepressant medications on hospitalized mental patients: a survey of published reports during a five-year period. J Nerv Ment Dis 141: 231–239PubMedCrossRefGoogle Scholar
  31. Wernicke JF, Brenner JD (1986) Fluoxetine effective in the long term treatment of depression. Br J Clin Pract [Suppl 46] 40: 17–23Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • P. Bech
    • 1
  1. 1.Department of PsychiatryFrederiksborg General HospitalHillerødDenmark

Personalised recommendations